Showing results (381-390 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|March 27, 2023
Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalpNuria García, Pere Guiró, Jordi Galván, et al.Drugs in Context|August 11, 2022
Drug costs in context: assessing drug costs in cost-of-illness analysesT Joseph Mattingly, Shannon WeathersDrugs in Context|August 11, 2022
Corrigendum: Diabetes: how to manage chronic kidney diseaseDrugs in Context|August 1, 2022
Advanced non-small-cell lung cancer: how to manage non-oncogene diseaseAndrea De Giglio, Alessandro Di Federico, Chiara Deiana, et al.Drugs in Context|May 6, 2021
Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep qualityRenato Vellucci, Gianluca De Rosa, Emanuele PiracciniDrugs in Context|February 27, 2023
Leveraging diagnostic stewardship within antimicrobial stewardship programmesKimberly C Claeys, Melissa D JohnsonDrugs in Context|August 17, 2022
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive diseaseGiulio Metro, Andrea De Giglio, Biagio Ricciuti, et al.Drugs in Context|December 22, 2025
Effectiveness of the antihistamine and anti-PAF effects of rupatadine in allergic diseases: off-label use in a case series studyRita Aguiar, Rocío Concepción Albores-Arguijo, Ewa Cichocka-Jarosz, et al.Drugs in Context|December 25, 2025
Sphingosine-1-phosphate receptor modulators in ulcerative colitis - a narrative review of current evidence and practical considerationsAnish J Kuriakose Kuzhiyanjal, Karishma Sethi-Arora, Gaurav B Nigam, et al.Drugs in Context|July 3, 2025
Long sustained response during second-line pembrolizumab plus lenvatinib in a patient with recurrent endometrial carcinoma: a case reportLaura Fabbri, Linda Galvani, Claudio ZamagniPageof 56